Sami-Sabinsa Group’s successful transfer of technology from the trial to the commercial field will further boost demand for C. forskohlii in healthcare applications. Sami-Sabinsa Group Limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results